Benzinga's Top #PreMarket Losers

Sarepta Therapeutics (NASDAQ: SRPT ) dipped 48.69% to $18.76 in the pre-market session. Sarepta reported a non-GAAP net loss of $21.3 million, or $0.63 per share. Piper Jaffray downgraded the stock from Overweight to Underweight. Hanwha SolarOne Co (NASDAQ: HSOL ) shares dropped 14.43% to $4.33 in pre-market trading